Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Palonosetron × Clear all

Phase

Phase 2 17 Phase 3 14 Phase NA 5 Phase 4 5 Phase 2/3 2 Phase 1/2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cyclophosphamide 553 pembrolizumab 432 Paclitaxel 394 Gemcitabine 376 Cisplatin 375 Carboplatin 370 Radiotherapy 333 fludarabine 314 Nivolumab 298 Bevacizumab 242 Docetaxel 239 Irinotecan 216 Magnetic Resonance Spectroscopy 211 Dexamethasone 198 Specimen Handling 193 Fluorouracil 193 Capecitabine 189 Cytarabine 181 Rituximab 179 fludarabine phosphate 172 Oxaliplatin 171 Biopsy 170 Temozolomide 169 Ipilimumab 165 Etoposide 160 Lenalidomide 159 Doxorubicin 151 Cetuximab 150 Radiation 145 Leucovorin 145

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01836705 2025-03-05

Effect of SAR302503 on ECG Activity in Patients With Solid Tumors

Bristol-Myers Squibb

Phase 1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡